Vitamin D analogs in cancer prevention and therapy

Anticancer Research

Volumn 26, Issue 4 A, 2006, Pages 2511-2514

  Reichrath, Jörg ^a   Tilgen, Wolfgang ^a   Diedrich, Klaus ^b   Friedrich, Michael ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

1,25(OH) 2D3; 1,25 dihydroxyvitamin D; Calcitriol; Prevention; VDR; Vitamin D; Vitamin D analogs; Vitamin D deficiency; Vitamin D insufficiency; Vitamin D receptor

Indexed keywords

1ALPHA,25 DIHYDROXY 19 NORVITAMIN D3; 25 HYDROXYVITAMIN D; ALITRETINOIN; ANTINEOPLASTIC AGENT; CALCITRIOL; CISPLATIN; DNA; DOCETAXEL; GLUCOCORTICOID; HISTONE DEACETYLASE INHIBITOR; KETOCONAZOLE; PACLITAXEL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER PREVENTION; CANCER THERAPY; CLINICAL STUDY; CLINICAL TRIAL; COLON CANCER; CONFERENCE PAPER; DOSE RESPONSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG SYNTHESIS; ENZYME INHIBITION; HEALTH PRACTITIONER; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; LABORATORY TEST; MEDICAL EDUCATION; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

HUMANS; NEOPLASMS; VITAMIN D;

EID: 33746623015     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Spina CS, Tangpricha V, Uskokovic M, Adorini L, Maehr H and Holick MF: Vitamin D and cancer. Anticancer Res 26: 2515-2524, 2006.
2. Grant WB and Garland CF: The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 26: 2687-2700, 2006.
3. Grant WB: The likely role of vitamin D from solar ultraviolet-B irradiance in increasing cancer survivial. Anticancer Res 26: 2605-2614, 2006.
4. Krause R, Matulla-Nolte B, Essers M, Brown A and Hopfenmüller W: UV radiation and cancer prevention - how is the evidence? Anticancer Res 26: 2723-2728, 2006.
5. Sieg J, Sieg A, Dreyhaupt J and Schmidt-Gayk H: Insufficient vitamin D supply as a possible cofactor of colorectal carcinogenesis. Anticancer Res 26: 2729-2734, 2006.
6. Colston KW, Lowe LC, Mansi JL and Campbell MJ: Vitamin D status and breast cancer risk. Anticancer Res 26: 2573-2580, 2006.
7. Peterlik M and Cross HS: Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res 26: 2581-2588, 2006.
8. Radermacher J, Diesel B, Seifert M, Tilgen W, Reichrath J, Fischer U and Meese E: Expression analysis of CYP27B1 in tumor biopsies and cell cultures. Anticancer Res 26: 2683-2686, 2006.
9. 3-1α-hydroxylase in normal and malignant breast tissue. Anticancer Res 26: 2615-2620, 2006.
10. Carlberg C and Dunlop TW: The impact of chromatin organization of vitamin D target genes. Anticancer Res 26: 2637-2646, 2006.
11. Cordes T, Becker S, Diedrich K, Reichrath J, Friedrich M and Diesing D: Modulation of MAPK ERK1 and ERK2 in VDR positive and negative breast cancer cell lines. Anticancer Res 26: 2749-2754, 2006.
12. Abedin SA, Banwell CM, Colston KW, Carlberg C and Campbell MJ: Epigenetic corruption of VDR signalling in malignancy. Anticancer Res 26: 2557-2566, 2006.
13. Eelen G, Verlinden L, De Clercq P, Vandewalle M, Bouillon R and Verstuyf A: Vitamin D analogs and coactivators. Anticancer Res 26: 2717-2722, 2006.
14. Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, Holick MF and Chen TC: Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res 26: 2567-2572, 2006.
15. Schuster I, Egger H, Herzig G, Reddy GS, Schmid JA, Schüssler M and Vorisek G: Selective inhibitors of vitamin D metabolism: new concepts and perspectives. Anticancer Res 26: 2653-2668, 2006.
16. Jones G, Byford V, West S, Masuda S, Ibrahim G, Kaufmann M, Knutson JC, Strugnell S, Mehta R, Rusell DW and Mangelsdorf DJ: Hepatic activation and inactivation of clinically-relevant vitamin D analogs and prodrugs. Anticancer Res 26: 2589-2596, 2006.
17. Lechner D, Bajna E, Adlercreutz H and Cross HS: Genistein and 17β-estradiol, but not equol, regulate vitamin D synthesis in human colon and breast cancer cells. Anticancer Res 26: 2597-2604, 2006.
18. 3, in human colon cancer cells. Anticancer Res 26: 2669-2682, 2006.
19. Moreno J, Krishnan AV, Peehl DM and Feldman D: Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway. Anticancer Res 26: 2525-2530, 2006.
20. 3 modulates expression of CLU in melanoma cell lines in vitro. Anticancer Res 26: 2707-2716, 2006.
21. Gombart AF, Luong QT and Koeffler HP: Vitamin D compounds: activity against microbes and cancer. Anticancer Res 26: 2531-2542, 2006.
22. Tremezaygues L, Sticherling M, Pföhler C, Friedrich M, Meineke V, Seifert M, Tilgen W and Reichrath J: Cutaneous photosynthesis of vitamin D: an evolutionary highly conserved endocrine system that protects against environmental hazards including UV-radiation and microbial infections. Anticancer Res 26: 2743-2748, 2006.
23. Pelczynska M, Switalska M, Maciejewska M, Jaroszewicz I, Kutner A and Opolski A: Antiproliferative activity of vitamin D compounds in combination with cytostatics. Anticancer Res 26: 2701-2706, 2006.
24. 3 modulates the response of human keratincytes to ionizing radiation exposure. Anticancer Res 26: 2735-2742, 2006.
25. Johnson CS, Muindi JR, Hershberger PA and Trump DL: The antitumor efficacy of calcitriol: preclinical studies. Anticancer Res 26: 2543-2550, 2006.
26. Trump DL, Muindi J, Fakih M, Yu W-D and Johnson CS: Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res 26: 2551-2556, 2006.
27. Beer TM and Myrthue A: Calcitriol in the treatment of prostate cancer. Anticancer Res 26: 2647-2652, 2006.
28. 3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system on coactivator recruitment. Anticancer Res 26: 2621-2632, 2006.
29. 3: synthesis and biological evualuation. Anticancer Res 26: 2633-2636, 2006.
30. Diesing D, Cordes T, Schilling P, Diedrich K and Friedrich M: Vitamin D metabolism in the human breast cancer cell line MCF-7. Anticancer Res 26: 2755-2760, 2006.